Bill

Bill > SB211


MT SB211

MT SB211
Revise emergency use of epinephrine in school setting to include nasal spray


summary

Introduced
01/24/2025
In Committee
02/13/2025
Crossed Over
02/13/2025
Passed
04/16/2025
Dead
Signed/Enacted/Adopted
04/17/2025

Introduced Session

2025 Regular Session

Bill Summary

AN ACT REVISING THE EMERGENCY USE OF EPINEPHRINE IN A SCHOOL SETTING TO INCLUDE NASAL SPRAY; AMING SECTIONS 20-5-420 AND 20-5-421, MCA; AND PROVIDING AN IMMEDIATE EFFECTIVE DATE.

AI Summary

This bill updates Montana's existing laws regarding the emergency use of epinephrine in school settings to explicitly include epinephrine nasal spray alongside existing autoinjectable epinephrine options. The legislation modifies two sections of state code to expand the definition of "medication" to include nasal spray epinephrine and allows schools to maintain a stock supply of this form of medication for emergency use. Schools that choose to stock epinephrine nasal spray must develop specific protocols, including staff training on anaphylaxis recognition and medication administration, obtaining a prescription with the school as the patient, and keeping the medication in a secure but accessible location. The bill maintains existing liability protections for schools and personnel, ensuring they are not legally responsible for injuries arising from epinephrine administration unless gross negligence or intentional misconduct can be proven. The legislation requires that after administering epinephrine, a student must report to a school nurse or adult, and emergency services (9-1-1) must be contacted. The bill becomes effective immediately upon passage and is designed to provide schools with more flexibility in managing potential life-threatening allergic reactions by allowing an additional form of emergency epinephrine treatment.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Chapter Number Assigned (on 04/17/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...